Sentinel lymph node biopsy with a gamma probe in patients with high-risk cutaneous squamous cell carcinoma: follow-up results of sentinel lymph node-negative patients

DEMİR H., Isken T., Kus E., Tan Y. Z., İŞGÖREN S., Gorur G., ...More

NUCLEAR MEDICINE COMMUNICATIONS, vol.32, no.12, pp.1216-1222, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 12
  • Publication Date: 2011
  • Doi Number: 10.1097/mnm.0b013e32834b76cf
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1216-1222
  • Keywords: cutaneous squamous cell carcinoma, gamma probe, high risk, lymphoscintigraphy, sentinel lymph node biopsy, VULVAR CANCER, MELANOMA, LYMPHOSCINTIGRAPHY, NECK, SKIN, LOCALIZATION, METASTASES, UPDATE, HEAD
  • Kocaeli University Affiliated: Yes


Objective Lymphoscintigraphy (LS) and sentinel lymph node biopsy have become the standard of care for melanoma and breast cancer. However, the data on patients with cutaneous squamous cell carcinoma (SCC) are limited. We aimed to evaluate and identify the role of LS and sentinel lymph node biopsy in patients with high-risk cutaneous SCC.